Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area
Evaluation of Antibacterial Soap for Treatment of Lymphedema and Elephantiasis in an Area Endemic for Lymphatic Filariasis
Sponsor: Centers for Disease Control and Prevention
Listed as NCT00139100, this NA trial focuses on Cellulitis and Lymphedema and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 6 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Feb 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- Procter and Gamble
- Ste. Croix Hospital, Leogane, Haiti
For direct contact, visit the study record on ClinicalTrials.gov .